Literature DB >> 14519823

Metabolism of tea flavonoids in the gastrointestinal tract.

Jeremy P E Spencer1.   

Abstract

There is considerable interest in the bioavailability of flavan-3-ols such as tea catechins and their bioactivity in vivo. Although flavanols such as catechin and epicatechin have long been characterized as powerful antioxidants in vitro, evidence suggests that these compounds undergo significant metabolism and conjugation during absorption in the small intestine and in the colon. In the small intestine these modifications lead primarily to the formation of glucuronide conjugates that are more polar than the parent flavanol and are marked for renal excretion. Other phase II processes lead to the production of O-methylated forms that have reduced antioxidant potential via the methylation of the B-ring catechol. Significant modification of flavanols also occurs in the colon where the resident microflora degrade them to smaller phenolic acids, some of which may be absorbed. Cell, animal and human studies have confirmed such metabolism by the detection of flavanol metabolites in the circulation and tissues. This review will highlight the major sites of flavanol metabolism in the gastrointestinal tract and the processes that give rise to potential bioactive forms of flavan-3-ols in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14519823     DOI: 10.1093/jn/133.10.3255S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  31 in total

1.  Enzymatic synthesis of substituted epicatechins for bioactivity studies in neurological disorders.

Authors:  Jack W Blount; Mario Ferruzzi; Dan Raftery; Giulio M Pasinetti; Richard A Dixon
Journal:  Biochem Biophys Res Commun       Date:  2011-12-07       Impact factor: 3.575

Review 2.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

3.  Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies.

Authors:  Lei Cao; Awewura Kwara; David J Greenblatt
Journal:  J Pharm Pharmacol       Date:  2017-09-05       Impact factor: 3.765

Review 4.  The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota.

Authors:  Małgorzata Makarewicz; Iwona Drożdż; Tomasz Tarko; Aleksandra Duda-Chodak
Journal:  Antioxidants (Basel)       Date:  2021-01-28

5.  Self-assembled curcumin-soluble soybean polysaccharide nanoparticles: Physicochemical properties and in vitro anti-proliferation activity against cancer cells.

Authors:  Kang Pan; Huaiqiong Chen; Seung Joon Baek; Qixin Zhong
Journal:  Food Chem       Date:  2017-11-08       Impact factor: 7.514

Review 6.  Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria.

Authors:  Sebastian Schaffer; Heike Asseburg; Sabine Kuntz; Walter E Muller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2012-06-17       Impact factor: 5.590

7.  Does 3-pentadecylcatechol, an urushiol derivative, get absorbed in the body? A rat oral administration experiment.

Authors:  Hang Yeon Jeong; Hyoung Jae Lee; Jeong-Yong Cho; Jae-Hak Moon
Journal:  Food Sci Biotechnol       Date:  2020-03-14       Impact factor: 2.391

Review 8.  The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.

Authors:  Di Chen; Q Ping Dou
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

9.  The traditional antidiarrheal remedy, Garcinia buchananii stem bark extract, inhibits propulsive motility and fast synaptic potentials in the guinea pig distal colon.

Authors:  O B Balemba; Y Bhattarai; C Stenkamp-Strahm; M S B Lesakit; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2010-08-16       Impact factor: 3.598

Review 10.  Cocoa, chocolate, and cardiovascular disease.

Authors:  Monica Galleano; Patricia I Oteiza; Cesar G Fraga
Journal:  J Cardiovasc Pharmacol       Date:  2009-12       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.